Veracyte, Inc. (VCYT): one to watch?
Wait — Q2 numbers actually beat and guidance was raised, but a flagged slowdown in its core Decipher test growth spooked the market on the earnings call.
Fell 20% in 1 trading day(s) — now $47.57
Why VCYT dropped
Veracyte reported Q2 2026 results on July 30 that beat estimates on both revenue and EPS and management raised full-year revenue guidance, yet the stock still cratered the next session; earnings-call commentary highlighted a "Decipher volume reset" (deceleration in its biggest product line) as a going-forward risk, which appears to be what spooked investors despite the headline beat.
How this scored 66/100
Bar length shows how much each metric is worth — a 10-point metric is twice as wide as a 5-point one. Hover any row for what it means.
🔒 Read the full AI analysis
Create a free account to unlock the bull case and the risks for VCYT — plus today's other picks.
Analysis generated by SmartStonks's AI from public fundamentals and news, first flagged 2026-07-31. Research only — not financial advice.